| 2025-09-19 |
详情>>
股本变动：
变动后总股本159219.25万股
|
| 2025-07-17 |
股东大会：
将于2025-08-05召开股东大会
会议内容 ▼▲
- 1.Approve the “Plan of Merger for the Merger of BRF S.A. Shares into Marfrig Global Foods S.A.” (“Plan of Merger”), entered into on May 15, 2025 between the Company and Marfrig Global Foods SA (“MGF”), which establishes the terms and conditions for the incorporation of all shares issued by BRF by MGF (with the exception of those held by MGF), as provided for in article 252 of Brazilian Federal Law No. 6,404/1976 (“Brazilian Corporations Law”)(“Merger”);
2.Approve the Merger, the effectiveness of which will be subject to the verification (or waiver, as applicable) of the Conditions Precedent (as defined in the Plan of Merger) and the advent of the date on which the Merger will be considered consummated, in accordance with the Plan of Merger (“Closing Date”);
3.Ratify the appointment of the specialized company Apsis Consultoria Empresarial Ltda., registered with the CNPJ/MF under no. 08.681.365/0001-30 and CRC/RJ under no. 005112/O-9, headquartered in the City of Rio de Janeiro, State of Rio de Janeiro, at Rua do Passeio, no. 62, 6th floor, Centro, CEP 20021-290, (“Appraisal Company”), as responsible for preparing (a) the appraisal report, at market value, of the shares issued by BRF to be incorporated by MGF, within the scope of the Merger (“Merger Appraisal Report”); and (b) the appraisal report containing the calculation of the exchange ratio of the shares held by the non-controlling shareholders of BRF, based on the net equity value of the shares of MGF and BRF, with both assets being appraised according to the same criteria and on December 31, 2024, at market prices, pursuant to article 264 of the Brazilian Corporations Law (“264 Appraisal Report”);
4.Approve the Merger Appraisal Report;
5.Approve the 264 Appraisal Report;
6.Authorize the Company’s managers to perform all acts necessary to consummate the Merger, including, without limitation, the subscription of common shares to be issued by MGF on behalf of BRF’s shareholders (except MGF) on the date of consummation of the Merger, pursuant to article 252, §2, of the Brazilian Corporations Law.
|
| 2025-05-27 |
股东大会：
将于2025-06-18召开股东大会
会议内容 ▼▲
- 1.Approve the “Plan of Merger for the Merger of BRF S.A. Shares into Marfrig Global Foods S.A.” (“Plan of Merger”), entered into on May 15, 2025 between the Company and Marfrig Global Foods SA (“MGF”), which establishes the terms and conditions for the incorporation of all shares issued by BRF by MGF (with the exception of those held by MGF), as provided for in article 252 of Brazilian Federal Law No. 6,404/1976 (“Brazilian Corporations Law”) (“Merger”);
2.Approve the Merger, the effectiveness of which will be subject to the verification (or waiver, as applicable) of the Conditions Precedent (as defined in the Plan of Merger) and the advent of the date on which the Merger will be considered consummated, in accordance with the Plan of Merger (“Closing Date”);
3.Ratify the appointment of the specialized company Apsis Consultoria Empresarial Ltda., registered with the CNPJ/MF under no. 08.681.365/0001-30 and CRC/RJ under no. 005112/O-9, headquartered in the City of Rio de Janeiro, State of Rio de Janeiro, at Rua do Passeio, no. 62, 6th floor, Centro, CEP 20021-290, (“Appraisal Company”), as responsible for preparing (a) the appraisal report, at market value, of the shares issued by BRF to be incorporated by MGF, within the scope of the Merger (“Merger Appraisal Report”); and (b) the appraisal report containing the calculation of the exchange ratio of the shares held by the non-controlling shareholders of BRF, based on the net equity value of the shares of MGF and BRF, with both assets being appraised according to the same criteria and on December 31, 2024, at market prices, pursuant to article 264 of the Brazilian Corporations Law (“264 Appraisal Report”);
4.Approve the Merger Appraisal Report;
5.Approve the 264 Appraisal Report;
6.Authorize the Company’s managers to perform all acts necessary to consummate the Merger, including, without limitation, the subscription of common shares to be issued by MGF on behalf of BRF’s shareholders (except MGF) on the date of consummation of the Merger, pursuant to article 252, §2, of the Brazilian Corporations Law.
|
| 2025-05-16 |
详情>>
业绩披露：
2025年一季报每股收益0.70巴西雷亚尔,归母净利润11.24亿巴西雷亚尔,同比去年增长122.66%
|
| 2025-04-30 |
详情>>
业绩披露：
2022年年报每股收益-3.01巴西雷亚尔,归母净利润-31.66亿巴西雷亚尔,同比去年增长-734.06%
|
| 2025-04-30 |
详情>>
业绩披露：
2024年年报每股收益1.94巴西雷亚尔,归母净利润32.13亿巴西雷亚尔,同比去年增长258.40%
|
| 2024-11-14 |
详情>>
业绩披露：
2024年三季报(累计)每股收益1.52巴西雷亚尔,归母净利润25.17亿巴西雷亚尔,同比去年增长190.55%
|
| 2024-11-13 |
财报披露：
美东时间 2024-11-13 盘后发布财报
|
| 2024-08-15 |
详情>>
业绩披露：
2024年中报每股收益0.90巴西雷亚尔,归母净利润14.93亿巴西雷亚尔,同比去年增长162.38%
|
| 2024-05-08 |
详情>>
业绩披露：
2024年一季报每股收益0.30巴西雷亚尔,归母净利润5.05亿巴西雷亚尔,同比去年增长148.84%
|
| 2024-04-19 |
详情>>
业绩披露：
2023年年报每股收益-1.49巴西雷亚尔,归母净利润-20.29亿巴西雷亚尔,同比去年增长35.93%
|
| 2024-02-28 |
股东大会：
将于2024-03-28召开股东大会
会议内容 ▼▲
- 1.At the Ordinary General Meeting:
(i)To take the Management’s accounts, examine, discuss and vote on the ManagementReport, the Financial Statements and other documents related to the year endedDecember 31, 2023.
(ii)To set the number of members to compose the Board of Directors.
(iii)To elect the members of the Board of Directors, and it is necessary, pursuant to CVMResolution No. 70/2022, the request of shareholders representing at least 5% (fivepercent) of the voting capital for the adoption of the multiple voting process.
(iv)To approve, pursuant to paragraphs 6 and 7 of article 20 of the Bylaws, theappointment of the Chairman and Vice-Chairman of the Board of Directors.
(v)To set the annual global compensation of the Company’s management for the fiscalyear 2024.
(vi)To elect the members of the Fiscal Council and their respective alternates.
(vii)To set the compensationof the Fiscal Council for the fiscal year2024.
2.At the Extraordinary General Meeting:
(i)To amend Article 3 of the Company’s Bylaws to include the activity of "provision oflaboratory and technical analysis services to third parties"among those included in theCompany's corporate purpose.
(ii)To amend Article 5, caput, of the Company’s Bylaws, in order to reflect the increasein the capital stock to R$ 13,653,417.953.36, divided into 1,682,473,246 commonshares, resulting from the public offering of primary distribution of common shares carriedout by the Company, in accordance with the approvals made at the meetings of theBoard of Directors held on 07.03.2023 and 07.13.2023.
(iii)To amend Article 7, caput, of the Company’s Bylaws, in order to increase theauthorized capital limit to two billion and one hundred and three million (2,103,000,000)of common shares.
(iv)To amend Article 20, caput, of the Company’s Bylaws, in order to establish that theBoard of Directors shall be composed of at least 7 (seven) and at most 10 (ten) members.
(v)Consolidate the Company’s Bylaws with the amendment approved in the previousitem.
(vi)To examine, discuss and approve the terms and conditions of the instruments ofprotocol and justification of the incorporations of VIP S.A. Empreendimentos eParticipacies Imobiliarias ("VIP") and PSA Laboratorio Veterinario Ltda.("PSA"and,together with VIP,"Companies"), Companies that, directly and indirectly, have BRF astheir sole partner, by the Company ("Incorporations"), entered into by the Company’smanagement and the Companies ("Protocols").
(vii)Ratify the appointment of Grant Thornton Auditores Independentes Ltda. (CNPJ No.10.830.108/0001-65) as the specialized company responsible for the preparation of theappraisal reports of the shareholders’ equity of the Companies, at book value ("Appraisal Reports").
(viii)Analize and approve the Appraisal Reports.
(ix)Approve the Incorporations, with the consequent extinction of the Companies, underthe terms and conditions established in the Protocols.
(x)Authorize the Company’s managers to perform all acts necessary for theimplementation of the Incorporations.
|
| 2023-11-13 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-2.22巴西雷亚尔,归母净利润-27.8亿巴西雷亚尔,同比去年增长-23.32%
|
| 2023-08-15 |
详情>>
业绩披露：
2023年中报每股收益-2.22巴西雷亚尔,归母净利润-23.93亿巴西雷亚尔,同比去年增长-15.01%
|
| 2023-06-02 |
股东大会：
将于2023-07-03召开股东大会
会议内容 ▼▲
- 1.Increase of the authorized capital limit, from the current one billion, three hundred and twenty-five million (1,325,000,000) common shares to one billion, eight hundred and twenty-five million(1,825,000,000) common shares, with the consequent amendment of the caput of article 7 of the Company's bylaws (“Company’s Bylaws”) and consolidation of the Company's Bylaws.
2.Deletion of article 41 of the Company’s Bylaws, under the condition precedent to the settlement of an eventual capital increase through the issuance of new shares by the Company ("Capital Increase") with the consequent deletion of cross references and renumbering of the other articles, and consolidation of the Company’s Bylaws. Additionally, the waiver to the shareholders and/or investors from conducting a Tender Offer referred to in article 41 of the Company's Bylaws, in the context of an eventual Capital Increase (regardless of whether the Capital Increase will be approved by the shareholders or by the Company's Board of Directors).
|
| 2023-05-16 |
详情>>
业绩披露：
2023年一季报每股收益-0.96巴西雷亚尔,归母净利润-10.34亿巴西雷亚尔,同比去年增长32.76%
|
| 2023-03-09 |
股东大会：
将于2023-04-12召开股东大会
会议内容 ▼▲
- At the Ordinary General Assembly:
(i) To take the Management's accounts, examine, discuss and vote on the Management Report, the Financial Statements and other documents for the year ended December 31, 2022.
(ii) Establish the annual global compensation of the Company's management for the year 2023.
(iii) Elect the members of the Fiscal Council.
(iv) Establish the compensation of the members of the Fiscal Council for the fiscal year 2023.
At the Special General Assembly:
(i) Amend article 3 of the Company's Bylaws to include the activities of "intermediation and agency of services and business in general, except real estate" and "provision of administrative services to third parties" in the Company's corporate purpose.
(ii) Amend article 33, paragraph 2, of the Company's Bylaws to expressly provide that the same member of the Audit and Integrity Committee may accumulate the characteristics of financial expert and independent director, in accordance with article 22, item V, item ‘c’, of B3's Novo Mercado Regulation.
(iii) Amend article 33, paragraph 7, of the Company's Bylaws to provide that the functions and activities of the Coordinator of the Audit and Integrity Committee will be defined in the internal regulations of the body, in accordance with article 22, item III, of B3's Novo Mercado Regulation.
(iv) Consolidate the Company's Bylaws with the approved amendments.
|
| 2022-03-02 |
股东大会：
将于2022-03-28召开股东大会
会议内容 ▼▲
- At the Ordinary General Assembly:
1.To take the Management’s accounts, examine, discuss and vote on the Management Report, the Financial Statements and other documents related to the fiscal year ended on December 31, 2021, including the absorption of the profit of such year by the balance of accumulated losses;
2.To set at 10 (ten) the number of members to compose the Board of Directors;
3.To elect the members of the Board of Directors, being necessary, pursuant to CVM Instruction No. 165/1991, the request of shareholders representing, at least, 5% (five percent) of the voting capital in order to adopt the multiple voting process;
4.To approve, pursuant to paragraphs 6 and 7 of article 20 of the Bylaws, the appointment of the Chairman and Vice-Chairman of the Board of Directors;
5.To set the annual global compensation of the Company's management for the fiscal year 2022;
6.To elect the members of the Fiscal Council;
7.To set the compensation of the members of the Fiscal Council for the fiscal year 2022.
At the Extraordinary General Shareholders’ Meeting:
(i)To resolve on the following amendments to the Company's Bylaws, as detailed in a draft with revision marks contained in the Management Proposal disclosed to the market:
(a) Amend article 5, caput, of the Company's Bylaws, in order to reflect the change in the capital stock of R$12.553.417.953,36 (twelve billion, five hundred and fifty-three million, four hundred and seventeen thousand, nine hundred and fifty-three reais and thirty-six centavos), divided into 812,473,246 (eight hundred and twelve million, four hundred and seventy-three thousand, two hundred and forty-six) common shares, all registered, book-entry and without par value, to R$13,053,417,953.36 (thirteen billion, fifty-three million, four hundred and seventeen thousand, nine hundred and fifty-three reais and thirty-six centavos), divided into 1,082,473,246 (one billion, eighty-two million, four hundred and seventy-three thousand, two hundred and forty-six) common shares, all registered, book-entry and without par value, as a result of the public offering, with restricted placement efforts, carried out by the Company as approved at the Extraordinary Shareholders' Meeting held on 01.17.2022 and at the Board of Directors' meetings held on 01.17.2022 and 02.01.2022;(b) Add item (vii) to article 16 of the Company's Bylaws, to provide for the competence of the General Meeting to approve the execution of transactions and business with related parties or the sale or contribution of assets, whenever, in any of these cases, the value of the transaction or business corresponds to more than 50% (fifty percent) of the value of the Company's total assets included in its latest balance sheet approved at the General Meeting, in accordance with the provisions of article 122, item X, of Law No. 6,404/1976, as amended by Law No. 14,195/2021;(c) Amend article 23, item (xxxvii), and article 25, item (vi), of the Company's Bylaws, to adjust them to the proposed wording for article 16, item (vii), of the Bylaws, in accordance with the new wording of article 122, item X, of Law No. 6,404/1976, provide by Law No. 14,195/2021;(d) Amend paragraph 1 of article 24 of the Company's Bylaws, to provide that the positions of Chairman of the Board of Directors and Global Chief Executive Officer cannot be cumulated by the same person, under any circumstances, as provided for in article 138, paragraph 3, of Law No. 6,404/1976, included by Law No. 14,195/2021, with the consequent exclusion of paragraph 2 of Article 24 of the Bylaws and renumbering of the following paragraphs, as well as cross-reference adjustments;
(ii) Consolidate the Company's Bylaws with the approved changes.
|
| 2021-12-17 |
股东大会：
将于2022-01-17召开股东大会
会议内容 ▼▲
- 1.To resolve on the proposal to amend the limit of authorization for increasing the Company's share capital, regardless of statutory amendment, with the consequent amendment of article 7 and consolidation of the Company's Bylaws;
2.To approve the Company's capital increase by means of a public offering for primary distribution, pursuant to CVM Instruction 476 of January 16, 2009 and other applicable regulations, of up to three hundred and twenty-five million (325,000,000) new common shares, registered and with no par value ("Shares"), including in the form of American Depositary Shares (ADS), represented by American Depositary Receipts (“ADR”) ("Capital Increase" and "Offering", respectively);
3.To establish that, of the total value of the Offering: (a) five hundred million reais (R$ 500,000,000.00) shall be allocated to the capital stock; and (b) the remaining amount of the value of the Offering will be allocated to the formation of a capital reserve, in accordance with the provisions of article 182, paragraph 1, item 'a', of Law No. 6,404/1976 ("Brazilian Corporate Law");
4.To authorize, for all legal purposes and effects, the Company's management to perform all acts necessary and/or convenient to implement the Capital Increase and the Offering;
5.To authorize the Board of Directors, should market conditions make the Capital Increase and the Offering not advisable, at its sole discretion, at any time, not to implement or cancel the Capital Increase and the Offering without the need for subsequent ratification by the Company's shareholders;
6.To authorize the Board of Directors to (a) establish the quantity of shares to be effectively issued (respecting the maximum quantity established by this EGM), (b) approve the Share Price, and (c) homologate the Capital Increase.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-26 |
股东大会：
将于2021-04-27召开股东大会
会议内容 ▼▲
- At the Ordinary General Shareholders’ Meeting:
1.To take the Management’s accounts, examine, discuss and vote on the Management Report, the Financial Statements and other documents related to the fiscal year ended on December 31, 2020, including the absorption of the profit of such year by the balance of accumulated losses;
2.To set the annual global compensation of the Company’s management for the year 2021;
3.To elect the members of the Fiscal Council;
4.To establish the compensation of the members of the Fiscal Council for the fiscal year 2021.
At the Extraordinary General Shareholders’ Meeting:
1.To resolve on the following amendments to the Company’s Bylaws, as detailed in a draft with revision marks contained in the Management Proposal disclosed to the market:
1.1.Amend Article 3 of the Company’s Bylaws, in order to include, in the corporate purpose: the (i) manufacture by its own or on demand, commercialization, export and import of pharmochemical products derived from animal slaughter; (ii) manufacture and commercialization of organic chemical products derived from animal slaughter; and (iii) manufacture, distribution and export of pharmaceutical ingredients derived from animal slaughter;
1.2.Amend Article 33 of the Company’s Bylaws, in order to (1) establish that the Coordinator of the Audit and Integrity Committee will be chosen by the Board of Directors and not by the members of the Audit and Integrity Committee; (2) establish that Audit and Integrity Committee’s regular meetings shall have a bimonthly periodicity and no longer monthly; and (3) exclude the obligation that the meetings between the Audit and Integrity Committee Coordinator and the members of the Board of Directors and the Fiscal Council be held quarterly;
2.Consolidate the Company’s Bylaws with the approved changes;
3.Resolve on the following changes to the Restricted Stocks Plan of the Company (“Restricted Stocks Plan”):
3.1.Exclude the concepts of “Parity Actions”, “Total Shareholder Return - TSR” and “Funds Committed”, and, therefore change items 1.1, 5.3, 5.3.1 and 7.1 and exclude itens 5.3.2 and 7.2 of the Restricted Stocks Plan;
3.2.Insert the possibility for the Company, at its sole discretion and subject to any restrictions and procedures provided for in the applicable legislation and regulation, to grant restricted shares in the form of American Depositary Receipts - ADRs, with the consequent inclusion of a new item 6.2 in the Restricted Stocks Plan;
3.3.Consolidate the competence of the Board of Directors to establish the effects of the Beneficiary's termination in relation to “Restricted Stock Not Fully Acquired”, with the consequent amendment of item 8.1 and the exclusion of the current items 8.2 and 8.3 of the Restricted Stocks Plan;
3.4.Implement wording adjustments, without material change of content, and consequently change items 1.1 (concepts of “Restricted Stock Not Fully Acquired” and “Committee”), 2.1, 3.1, 3.2, 4.1, 4.2 (d), 4.3, 6.1, 7.3, 7.4, 10.2 and 10.3 and the exclusion of the current item 6.2 of the Restricted Stocks Plan.
|
| 2020-03-27 |
股东大会：
将于2020-04-27召开股东大会
会议内容 ▼▲
- At the Ordinary General Shareholders’ Meeting:
1.To take the Management’s accounts, examine, discuss and vote on the Management Report, the Financial Statements and other documents related to the fiscal year ended on December 31, 2019, including the absorption of the profit of such year by the balance of accumulated losses;
2.To set at 10 (ten) the number of members to compose the Company’s Board of Directors;
3.To elect the members of the Board of Directors, being necessary, under the terms of CVM Instruction No. 165/91, the requirement of shareholders representing, at least, 5% (five percent) of the voting capital so that the process of multiple voting is adopted;
4.To approve, pursuant to paragraphs 6 and 7 of article 20 of the Bylaws, the appointment of the Chairman and Vice-Chairman of the Board of Directors;
5.To set the annual global compensation of the Company’s management for the year 2020;
6.To elect members of the Fiscal Council;
7.To establish the compensation of the members of the Fiscal Council for the fiscal year 2020.
At the Extraordinary General Shareholders’ Meeting:
8.To amend Article 21 of the Company’s Bylaws, in order to adjust the periodicity of the ordinary meetings of the Board of Directors, establishing that such body must meet, ordinarily, at least 8 (eight) times a year;
9.To authorize the execution of indemnity agreements between the Company and the new members of the Board of Directors that may be elected at the Ordinary General Shareholders’ Meeting to be held cumulatively with this Extraordinary General Shareholders’ Meeting;
10.To amend the Stock Option Plan and the Restricted Stocks Plan of the Company.
|
| 2019-04-01 |
股东大会：
将于2019-04-29召开股东大会
会议内容 ▼▲
- 1.To take the account of the managers, to examine, discuss and vote on the Management Report, Financial Statements and other documents related to the fiscal year ended on December 31, 2018;
2.To set the annual global compensation of the management for the 2019 fiscal year;
3.To authorize the increase in value of the annual global compensation of the management for the 2019 fiscal year, to be applicable in case the Board of Directors decide for the increase in up to eight of the number of the members of the Company’s Executive Board;
4.To elect the members of the Fiscal Council;
5.To set the global compensation of the members of the Fiscal Council for the 2019 fiscal year.
|
| 2019-03-11 |
股东大会：
将于2019-04-24召开股东大会
|
| 2019-02-11 |
股东大会：
将于2019-01-31召开股东大会
会议内容 ▼▲
- 1.Sale Approval of Europe and Thailand Companies;
2.Appointment Independent Member CAI;
3.Election of Chief Financial and Investor Relations Officer.
|
| 2018-11-13 |
股东大会：
将于2018-12-12召开股东大会
会议内容 ▼▲
- 1.To review, discuss, and approve the terms and conditions of the protocol and justification of the merger of SHB Comércio e Indústria de Alimentos S.A. (“SHB”) with and into the Company (“Merger”) executed by the management of both the Company and SHB (“Protocol and Justification”);
2.To ratify the appointment of the specialized company KPMG Auditores Independentes (National Register of Legal Entities (CNPJ) under No. 57.755.217/0001-29) for preparing the appraisal report for SHB’s shareholders’ equity, at book value (“Appraisal Report”);
3.To approve the Appraisal Report;
4.To approve the Merger and consequent winding-up of SHB, under the terms and conditions provided for in the Protocol and Justification;
5.To authorize the managers of the Company to perform any and all acts required for the Merger.
|
| 2018-10-05 |
股东大会：
将于2018-11-05召开股东大会
会议内容 ▼▲
- 1.To resolve on the following amendments to the Company Bylaws, as detailed in the draft presented with review marks in the Management Proposal disclosed to the market on October 4, 2018:
1a.To adjust the Company’s Bylaws to the new Regulation of the Novo Mercado, which entered into force as of January 02, 2018, by means (I) of the amendments to article 1, paragraphs 1 and 2; to article 16, item iv; to article 19, paragraph 2; to article 20, caput and paragraph 1; to article 23, item xxii; to article 24, paragraph 1; to article 30, paragraph 2; to article 33, paragraphs 3 and 7; to article 39, caput and paragraph 1; to current article 41, paragraph one; to current article 42, caput; to current article 49, caput; and to current article 51; (II) of the insertion of the new item vi to article 16; of new paragraphs 2, 3 and 4 to article 20; of new item xxxvii to article 23; of new paragraph 2 to article 24, of new item vii to article 25; of new paragraphs 3 and 4 to article 39; and of new articles 42, 43 and 44; and (III) of the exclusion of item v from article 16; of item xxi from article 23; of paragraphs 2 and 3 from article 39; of current articles 40, 41, 44, 45, 46, 47 and 48;
1b.To adjust certain provisions of the Company Bylaws pursuant to the recommendations of the Brazilian Code of Corporate Governance - CBGC, with (I) the inclusion of paragraph 5 to article 20; of paragraph 8 to article 21; of new items ii, xx, xxiii and xxiv to article 23; and (II) the amendment to the current items i and xxi, of article 23; to new item xxxviii of new in article 23; item vii to be inserted in article 25; and to paragraphs 3 and 11 of article 33;
1c.To review the financial competence of the Board of Directors and of the Board of Officers of the Company, by means (I) of the amendment to article 23, current items xvi, xxiv, xxvii, xxviii, xxix, xxx, xxxii, xxxiii, xxxvi and xxxvii; and to article 25, item iv; and (II) of the exclusion of paragraphs 1 and 2 of article 23; and of current items vii and viii of article 25;
2.to consolidate the Company Bylaws in order to reflect the approved amendments.
|
| 2018-04-26 |
股东大会：
将于2018-05-25召开股东大会
会议内容 ▼▲
- 1.Rectify the amount of the annual global compensation of the Board of Directors and Board of Directors for the 2018 fiscal year;
2.Modify the Company’s Restricted Shares Plan;
3.To authorize the execution of indemnity agreements between the Company and the current members of the Board of Directors.
|
| 2018-04-17 |
股东大会：
将于2018-04-26召开股东大会
会议内容 ▼▲
- Ordinary General Shareholders’ Meeting
1.To examine, discuss and vote on the Management Report, Financial Statements and other documents related to the financial year ending on December 31, 2017;
2.To set the global remuneration of the officers Board of Directors and Executive Management (“Manager”) for the 2018 financial year;
3.To elect the members of the Fiscal Council;
4.To set the global remuneration of the members of the Fiscal Council for the 2018 financial year.
Extraordinary General Shareholders’ Meeting
1.As requested by the shareholders Caixa de Previdencia dos Funcionários do Banco do Brasil – Previ and Fundao Petrobras de Seguridade Social – Petros: (a) removal of all members of the Board of Directors; (b) approval of the number of 10 members to compose the Board of Directors; (c) Election of new members to fill the positions on the Board of Directors; and (d) election of the Chairman and Vice-Chairman of the Board of Directors;
2.Amend Article 30, § 3, of the Company′s Bylaws, as to provide that the meetings of the Fiscal Council are held periodically, in terms of the Internal Rules of the body;
3.Consolidate the Company′s Bylaws.
|
| 2018-04-09 |
股东大会：
将于2018-04-05召开股东大会
会议内容 ▼▲
- 1.Discussions regarding the Company’s Ordinary and Extraordinary Shareholders Meeting
|
| 2017-03-27 |
股东大会：
将于2017-04-26召开股东大会
会议内容 ▼▲
- Ordinary General Meeting
1.To examine, discuss and vote on the Management Report, Financial Statements and other documents related to the financial year ending on December 31, 2016;
2.To ratify the distribution of the remuneration to shareholders (Interest on Own Equity), as resolved by the Board of Directors;
3. To establish the number of members of the Board of Directors;
4.To elect the members of the Board of Directors;
5.To appoint the Chairman and the Deputy Chairman of the Board of Directors;
6.To set the global remuneration of the officers (Board of Directors and Executive Management) for the 2017 financial year;
7.To elect the members of the Fiscal Council;
8.To set the global remuneration of the Fiscal Council for the 2017 financial year;
Extraordinary General Meeting
1.To amend the Restricted Stocks Plan.
|
| 2016-03-02 |
股东大会：
将于2016-04-07召开股东大会
会议内容 ▼▲
- EXTRAORDINARY GENERAL MEETING
1. To approve the change in article 5, caput, of the Company’s Bylaws, that deals with the capital stock, to reflect the new number of shares into which the Company′s capital stock is divided, due to the cancellation of the shares approved at the meeting of the Board of Directors held on February 25, 2016.
2. To alter and consolidate the Company Bylaws.
3. To establish the annual global remuneration of the Management and the Fiscal Council for the 2016 fiscal year and re-ratify the annual and global remuneration made in 2015.
4. To change the mass circulation newspapers in which the Company places its legal publications.
ANNUAL GENERAL MEETING
1. To examine, discuss and vote on the Management Report, Financial Statements and other documents related to the financial year ending December 31, 2015, and decide on the allocation of the profits.
2. To ratify the distribution of the remuneration to the shareholders (Interest on Equity and Dividends), as decided by the Board of Directors.
3. To elect the members of the Fiscal Council of the Company.
|
| 2015-06-19 |
除权日：
美东时间 2015-06-30 每股派息0.16美元
|
| 2014-12-19 |
除权日：
美东时间 2015-01-02 每股派息0.20美元
|
| 2014-06-20 |
除权日：
美东时间 2014-07-01 每股派息0.19美元
|
| 2013-12-23 |
除权日：
美东时间 2014-01-02 每股派息0.18美元
|
| 2013-06-19 |
除权日：
美东时间 2013-07-01 每股派息0.19美元
|
| 2013-04-10 |
除权日：
美东时间 2013-04-22 每股派息0.03美元
|
| 2012-12-21 |
除权日：
美东时间 2013-01-02 每股派息0.10美元
|
| 2012-06-20 |
复牌提示：
2011-07-13 08:00:35 停牌，复牌日期 2011-07-13 14:18:16
|
| 2012-06-19 |
除权日：
美东时间 2012-06-29 每股派息0.06美元
|
| 2011-12-16 |
除权日：
美东时间 2011-12-29 每股派息0.21美元
|
| 2011-06-20 |
除权日：
美东时间 2011-06-30 每股派息0.21美元
|
| 2010-12-17 |
除权日：
美东时间 2010-12-29 每股派息0.14美元
|
| 2010-06-17 |
除权日：
美东时间 2010-06-29 每股派息0.03美元
|